{"hands_on_practices": [{"introduction": "The efficacy of a therapeutic antibody is fundamentally tied to its binding affinity for its target. This exercise grounds the abstract concept of the equilibrium dissociation constant, $K_D$, in the measurable kinetic parameters of binding and unbinding. By calculating $K_D$ from the association ($k_{\\text{on}}$) and dissociation ($k_{\\text{off}}$) rates, and then using it to determine target occupancy at a therapeutic concentration, you will practice a core skill in pharmacology and antibody engineering [@problem_id:5016628].", "problem": "A humanized monoclonal Immunoglobulin G (IgG) is developed to neutralize a soluble autoantigen implicated in pathologic activation of adaptive immunity in systemic autoimmunity. Surface Plasmon Resonance (SPR) measurements at $37^{\\circ}\\mathrm{C}$ yield an association rate constant $k_{\\text{on}}$ and a dissociation rate constant $k_{\\text{off}}$ for the antibody–antigen interaction under buffered physiological conditions. Assume a single non-cooperative binding site per antigen (monovalent epitope), no avidity or rebinding effects, and that free antibody concentration approximates total antibody concentration because antibody is in large molar excess over antigen in plasma.\n\nGiven $k_{\\text{on}} = 1.2 \\times 10^{6}\\ \\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$ and $k_{\\text{off}} = 8.0 \\times 10^{-4}\\ \\mathrm{s}^{-1}$, and a steady-state free antibody concentration of $[{\\mathrm{Ab}}] = 20\\ \\mathrm{nM}$ achieved in patients, use the law of mass action and equilibrium definitions to derive an expression for the equilibrium dissociation constant $K_{D}$ and the antigen occupancy fraction by antibody at equilibrium. Then compute both quantities from the provided parameters.\n\nRound the equilibrium dissociation constant to three significant figures and express it in nanomolar, and round the antigen occupancy fraction to four significant figures and express it as a unitless decimal fraction.", "solution": "The problem statement will first be validated according to the specified protocol.\n\n### Step 1: Extract Givens\n- Humanized monoclonal Immunoglobulin G (IgG) neutralizes a soluble autoantigen.\n- Interaction measured via Surface Plasmon Resonance (SPR) at a temperature $T = 37^{\\circ}\\mathrm{C}$.\n- Association rate constant: $k_{\\text{on}} = 1.2 \\times 10^{6}\\ \\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}$.\n- Dissociation rate constant: $k_{\\text{off}} = 8.0 \\times 10^{-4}\\ \\mathrm{s}^{-1}$.\n- Binding is non-cooperative with a single binding site per antigen (monovalent).\n- No avidity or rebinding effects are considered.\n- Free antibody concentration approximates total antibody concentration.\n- Steady-state free antibody concentration in patients: $[{\\mathrm{Ab}}] = 20\\ \\mathrm{nM}$.\n- The task is to derive expressions for and compute the equilibrium dissociation constant ($K_{D}$) and the antigen occupancy fraction ($\\theta$) at equilibrium.\n- Required rounding for $K_D$: three significant figures, expressed in nanomolar ($\\mathrm{nM}$).\n- Required rounding for $\\theta$: four significant figures, expressed as a unitless decimal fraction.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is evaluated against the validation criteria:\n- **Scientifically Grounded**: The problem is based on the law of mass action, a fundamental principle of chemical kinetics, and applies it to a standard scenario in immunology and pharmacology—the binding of a monoclonal antibody to its antigen. The concepts of association/dissociation rate constants, equilibrium dissociation constant, and fractional occupancy are cornerstones of receptor theory and antibody-antigen interactions. The given values for $k_{\\text{on}}$ and $k_{\\text{off}}$ are realistic for a high-affinity IgG antibody.\n- **Well-Posed**: The problem is clearly defined. It provides all necessary data ($k_{\\text{on}}$, $k_{\\text{off}}$, $[{\\mathrm{Ab}}]$) and simplifying assumptions (monovalent interaction, antibody in excess) to derive and calculate the requested quantities. A unique and stable solution exists.\n- **Objective**: The problem is stated using precise, objective, and quantitative language. It is free of any subjective or opinion-based claims.\n\nThe problem does not exhibit any of the listed flaws (Scientific Unsoundness, Non-Formalizable, Incomplete Setup, Unrealistic, Ill-Posed, Pseudo-Profound, or Outside Scientific Verifiability).\n\n### Step 3: Verdict and Action\nThe problem is **valid**. A complete solution will be provided.\n\n### Solution Derivation and Calculation\nThe interaction between the antibody (${\\mathrm{Ab}}$) and the antigen (${\\mathrm{Ag}}$) is a reversible binding reaction, which can be represented as:\n$$ {\\mathrm{Ab}} + {\\mathrm{Ag}} \\underset{k_{\\text{off}}}{\\stackrel{k_{\\text{on}}}{\\rightleftharpoons}} {\\mathrm{AbAg}} $$\nwhere ${\\mathrm{AbAg}}$ is the antibody-antigen complex.\n\nThe rate of association ($v_{\\text{on}}$), according to the law of mass action, is proportional to the concentrations of the free reactants:\n$$ v_{\\text{on}} = k_{\\text{on}} [{\\mathrm{Ab}}] [{\\mathrm{Ag}}] $$\nThe rate of dissociation ($v_{\\text{off}}$) is proportional to the concentration of the complex:\n$$ v_{\\text{off}} = k_{\\text{off}} [{\\mathrm{AbAg}}] $$\nAt equilibrium, the rate of association equals the rate of dissociation:\n$$ v_{\\text{on}} = v_{\\text{off}} $$\n$$ k_{\\text{on}} [{\\mathrm{Ab}}] [{\\mathrm{Ag}}] = k_{\\text{off}} [{\\mathrm{AbAg}}] $$\n\nThe equilibrium dissociation constant, $K_{D}$, is defined as the ratio of the concentrations of the dissociated species to the concentration of the complex at equilibrium. It can be derived from the equilibrium condition:\n$$ K_{D} = \\frac{[{\\mathrm{Ab}}] [{\\mathrm{Ag}}]}{[{\\mathrm{AbAg}}]} = \\frac{k_{\\text{off}}}{k_{\\text{on}}} $$\nThis is the required expression for $K_{D}$.\n\nNext, we compute the value of $K_{D}$ using the given rate constants:\n$$ k_{\\text{on}} = 1.2 \\times 10^{6}\\ \\mathrm{M}^{-1}\\,\\mathrm{s}^{-1} $$\n$$ k_{\\text{off}} = 8.0 \\times 10^{-4}\\ \\mathrm{s}^{-1} $$\n$$ K_{D} = \\frac{8.0 \\times 10^{-4}\\ \\mathrm{s}^{-1}}{1.2 \\times 10^{6}\\ \\mathrm{M}^{-1}\\,\\mathrm{s}^{-1}} = \\frac{8.0}{1.2} \\times 10^{-10}\\ \\mathrm{M} \\approx 6.666... \\times 10^{-10}\\ \\mathrm{M} $$\nThe problem requires the answer to be in nanomolar ($\\mathrm{nM}$). We use the conversion $1\\ \\mathrm{nM} = 10^{-9}\\ \\mathrm{M}$, or $1\\ \\mathrm{M} = 10^{9}\\ \\mathrm{nM}$:\n$$ K_{D} = (6.666... \\times 10^{-10}\\ \\mathrm{M}) \\times (10^{9}\\ \\mathrm{nM}/\\mathrm{M}) = 0.6666...\\ \\mathrm{nM} $$\nRounding to three significant figures gives:\n$$ K_{D} \\approx 0.667\\ \\mathrm{nM} $$\n\nThe antigen occupancy fraction, denoted here by $\\theta$, is the fraction of the total antigen population that is bound by the antibody at equilibrium.\n$$ \\theta = \\frac{\\text{Concentration of bound antigen}}{\\text{Concentration of total antigen}} = \\frac{[{\\mathrm{AbAg}}]}{[{\\mathrm{Ag}}] + [{\\mathrm{AbAg}}]} $$\nTo express $\\theta$ in terms of $[{\\mathrm{Ab}}]$ and $K_{D}$, we rearrange the definition of $K_{D}$:\n$$ [{\\mathrm{AbAg}}] = \\frac{[{\\mathrm{Ab}}] [{\\mathrm{Ag}}]}{K_{D}} $$\nSubstituting this into the expression for $\\theta$:\n$$ \\theta = \\frac{\\frac{[{\\mathrm{Ab}}] [{\\mathrm{Ag}}]}{K_{D}}}{[{\\mathrm{Ag}}] + \\frac{[{\\mathrm{Ab}}] [{\\mathrm{Ag}}]}{K_{D}}} $$\nWe can cancel the free antigen concentration $[{\\mathrm{Ag}}]$ from the numerator and denominator (assuming $[{\\mathrm{Ag}}] \\neq 0$):\n$$ \\theta = \\frac{\\frac{[{\\mathrm{Ab}}]}{K_{D}}}{1 + \\frac{[{\\mathrm{Ab}}]}{K_{D}}} $$\nMultiplying the numerator and denominator by $K_{D}$ gives the simplified expression for the antigen occupancy fraction:\n$$ \\theta = \\frac{[{\\mathrm{Ab}}]}{K_{D} + [{\\mathrm{Ab}}]} $$\nThis is the required expression for $\\theta$.\n\nNow, we compute the value of $\\theta$ using the given steady-state free antibody concentration $[{\\mathrm{Ab}}] = 20\\ \\mathrm{nM}$ and the previously calculated value for $K_{D}$. For precision, the unrounded value of $K_{D}$ should be used.\n$$ [{\\mathrm{Ab}}] = 20\\ \\mathrm{nM} $$\n$$ K_{D} = 0.6666...\\ \\mathrm{nM} = \\frac{2}{3}\\ \\mathrm{nM} $$\n$$ \\theta = \\frac{20\\ \\mathrm{nM}}{\\frac{2}{3}\\ \\mathrm{nM} + 20\\ \\mathrm{nM}} = \\frac{20}{\\frac{2}{3} + \\frac{60}{3}} = \\frac{20}{\\frac{62}{3}} = \\frac{20 \\times 3}{62} = \\frac{60}{62} = \\frac{30}{31} $$\nConverting this fraction to a decimal:\n$$ \\theta = \\frac{30}{31} \\approx 0.9677419... $$\nRounding to four significant figures gives:\n$$ \\theta \\approx 0.9677 $$\nThe problem assumption that free antibody concentration approximates total antibody concentration is justified because the high occupancy ($\\theta \\approx 97\\%$) implies that the concentration of bound antibody ($[{\\mathrm{AbAg}}]$) is nearly equal to the total antigen concentration. As long as the total antigen concentration is much less than the total antibody concentration, the free antibody concentration will remain close to its total value.", "answer": "$$\\boxed{\\begin{pmatrix} 0.667 & 0.9677 \\end{pmatrix}}$$", "id": "5016628"}, {"introduction": "Beyond single molecular interactions, immune responses depend on complex, multi-step cellular pathways. This problem moves into the realm of systems-level thinking, focusing on the quality control of antigen presentation by MHC class I molecules. You will be asked to integrate your knowledge of the peptide loading complex, particularly the role of tapasin in peptide editing, to predict the cascading effects of its deficiency on the T cell response to a viral infection [@problem_id:5016593]. This type of conceptual analysis is vital for understanding the basis of immunodeficiencies and designing immune-based therapies.", "problem": "A research team is modeling the consequences of a genetic deficiency of tapasin, a core component of the peptide loading complex that bridges the Transporter associated with Antigen Processing (TAP) and Major Histocompatibility Complex (MHC) class I in the Endoplasmic Reticulum (ER). They are focused on predicting how tapasin deficiency alters the peptide repertoire presented by MHC class I molecules and the downstream $CD8^+$ T cell response during an acute viral infection. The team will use the following fundamental base to guide their predictions.\n\nFundamental base:\n- Peptides generated in the cytosol enter the ER via TAP and bind nascent MHC class I molecules. Tapasin participates in a peptide editing process in which peptides with higher binding stability are favored to form stable complexes that exit the ER.\n- For a given peptide–MHC class I complex, the dissociation rate constant $k_{\\text{off}}$ determines complex stability. The complex half-life $t_{1/2}$ satisfies $t_{1/2} = \\ln 2 / k_{\\text{off}}$. Lower $k_{\\text{off}}$ implies longer $t_{1/2}$ and higher surface stability.\n- The density and dwell time of peptide–MHC class I complexes at the cell surface influence T cell receptor (TCR) triggering and the magnitude and hierarchy of $CD8^+$ T cell responses (immunodominance). More stable, higher-density complexes generally elicit stronger responses.\n- ER quality control preferentially allows export of stable peptide–MHC class I complexes; suboptimally loaded complexes tend to be retained or are unstable at the surface.\n\nConsider a mouse model lacking tapasin but with intact proteasomes and TAP, infected with an acute cytopathic virus. Predict how tapasin deficiency affects: (i) the diversity and average stability of the peptide repertoire bound by each MHC class I allotype at the cell surface, and (ii) the magnitude and immunodominance hierarchy of virus-specific $CD8^+$ T cell responses and viral control. Choose the single best integrated prediction.\n\nA. Surface MHC class I complexes exhibit reduced average stability and shorter half-lives due to loading of suboptimal peptides, with a more chemically heterogeneous (less edited) peptide repertoire per allotype despite reduced overall MHC class I abundance; $CD8^+$ T cell responses are blunted with altered immunodominance and impaired viral clearance.\n\nB. Surface MHC class I levels increase because peptide-free heavy chains accumulate and are exported; peptide repertoire narrows to only the highest affinity peptides via TAP alone; $CD8^+$ T cell responses to dominant epitopes are enhanced and viral clearance is improved.\n\nC. MHC class I peptide stability and repertoire are unchanged because tapasin primarily acts on MHC class II; $CD8^+$ T cell responses and viral control are unaffected.\n\nD. Peptide diversity decreases but average stability of surface complexes increases because only the highest affinity peptides can load without editing; $CD8^+$ T cell responses are preserved in magnitude but narrowed in specificity, yielding normal viral control.\n\nE. Both diversity and stability of peptide–MHC class I complexes increase in the absence of editing because more high-affinity peptides can load simultaneously, producing broader and stronger $CD8^+$ T cell responses with superior viral control.", "solution": "We start from the fundamental base of MHC class I antigen processing and peptide editing. Tapasin functions within the peptide loading complex to promote the association of MHC class I with peptides that form stable complexes. Mechanistically, tapasin increases the likelihood that peptides with low dissociation rate $k_{\\text{off}}$ (hence longer $t_{1/2} = \\ln 2 / k_{\\text{off}}$) will be selected and that suboptimal peptide–MHC class I complexes will undergo further exchange. In the absence of tapasin, the peptide editing stringency decreases. Consequently, several outcomes follow from the base principles.\n\nFirst, peptide selection and complex stability. Without tapasin, MHC class I molecules more readily bind available peptides without stringent editing. This increases the fraction of complexes incorporating suboptimal peptides with higher $k_{\\text{off}}$, which by $t_{1/2} = \\ln 2 / k_{\\text{off}}$ implies shorter half-lives at the cell surface. Reduced complex stability also feeds into ER quality control: fewer complexes reach the surface, and those that do tend to dissociate more rapidly. Thus, the average surface stability per allotype decreases and total surface abundance usually declines.\n\nSecond, peptide repertoire characteristics. Editing focuses the repertoire onto a subset of peptides with high stability; removal of editing relaxes this constraint. If one considers the set of peptide species that can bind a given MHC class I allotype conditional on reaching the surface, removal of editing tends to produce a more heterogeneous set (higher chemical diversity) but with lower average stability because many peptides will be suboptimal binders. This effect coexists with a reduction in total MHC class I complex numbers at the surface.\n\nThird, $CD8^+$ T cell activation and immunodominance. TCR triggering probability depends on both the density of peptide–MHC class I ligands and their dwell time, which correlates inversely with $k_{\\text{off}}$. Decreased density and decreased half-life combine to reduce the magnitude of T cell priming and effector responses. Moreover, immunodominance hierarchies depend on which epitopes are stably displayed; altering stability and density will shift or flatten these hierarchies, potentially allowing subdominant epitopes to be presented but not necessarily to an extent sufficient to compensate for reduced stability. The net effect is an overall blunted $CD8^+$ T cell response and impaired viral clearance.\n\nWe now evaluate each option.\n\nA. This option states that surface MHC class I complexes have reduced average stability and shorter half-lives due to loading of suboptimal peptides, with a more chemically heterogeneous repertoire per allotype despite reduced overall abundance, and that $CD8^+$ T cell responses are blunted with altered immunodominance and impaired viral clearance. This aligns with the reasoning above: lower average stability ($k_{\\text{off}}$ increased, $t_{1/2}$ decreased), decreased total surface expression due to compromised ER quality control, a less-edited and therefore more heterogeneous peptide set reaching the surface, and reduced T cell responses with shifted immunodominance and worse control. Verdict: Correct.\n\nB. This option claims increased surface levels due to export of peptide-free heavy chains, a narrowed repertoire to only highest affinity peptides via TAP alone, and enhanced responses. TAP does not substitute for tapasin’s editing; peptide-free heavy chains are not efficiently exported and are unstable at the surface. Without editing, the repertoire does not narrow to only high-affinity peptides; rather, suboptimal peptides are more likely to be loaded. Enhanced responses are inconsistent with reduced stability and density. Verdict: Incorrect.\n\nC. This asserts no change because tapasin acts on MHC class II. Tapasin is a canonical component of the MHC class I peptide loading complex, not MHC class II, where HLA-DM and HLA-DO govern editing. Therefore, changes are expected for MHC class I; $CD8^+$ responses are affected. Verdict: Incorrect.\n\nD. This suggests decreased diversity but increased stability because only highest affinity peptides load without editing, preserving response magnitude and viral control. This reverses the role of editing: editing increases selection stringency for stable binders; without it, stability decreases on average and diversity among the few exported complexes increases in chemical variety but with lower stability. Preservation of magnitude and normal control contradict the expected decrease in density and half-life. Verdict: Incorrect.\n\nE. This posits increases in both diversity and stability due to absent editing allowing more high-affinity peptides to load simultaneously, yielding stronger responses. The absence of editing does not increase stability; it permits more low-affinity loading, decreasing average stability and half-life. Stronger responses are therefore unlikely. Verdict: Incorrect.\n\nThus, the integrated prediction in option A best conforms to the foundational principles of peptide editing, binding kinetics $t_{1/2} = \\ln 2 / k_{\\text{off}}$, and TCR triggering dependencies on ligand density and dwell time. Option A is correct.", "answer": "$$\\boxed{A}$$", "id": "5016593"}, {"introduction": "The fate of an entire cell population can often be described using the principles of population dynamics, a powerful tool in quantitative biology. This exercise challenges you to apply a system of differential equations to model the outcomes of peripheral T cell tolerance—a critical process for preventing autoimmunity. By calculating the number of cells that are deleted, converted into regulatory T cells, or survive over time, you will gain hands-on experience with the mathematical models that help us understand and predict the balance between immunity and self-tolerance at the organismal level [@problem_id:5016553].", "problem": "A self-reactive T cell population encounters a constant level of self-antigen in a non-inflammatory environment, where peripheral tolerance mechanisms dominate. In such settings, self-reactive conventional T cells can undergo clonal deletion (cell death) or convert into induced regulatory T cells (Tregs). Assume a well-mixed compartment and model cell population dynamics using the law of mass action with linear per-cell rates. Let $S(t)$ denote the number of surviving self-reactive conventional T cells at time $t$, and let $R(t)$ denote the number of induced Tregs at time $t$. Assume that the per-cell deletion rate is $\\delta$ (in $\\mathrm{day}^{-1}$), the per-cell conversion rate into Tregs is $\\alpha$ (in $\\mathrm{day}^{-1}$), and the per-cell loss rate of induced Tregs is $\\mu$ (in $\\mathrm{day}^{-1}$). The governing system is:\n- $ \\dfrac{dS}{dt} = -(\\delta + \\alpha) \\, S(t) $,\n- $ \\dfrac{dR}{dt} = \\alpha \\, S(t) - \\mu \\, R(t) $,\nwith initial conditions $S(0) = S_0$ and $R(0) = R_0$. Define the cumulative number of deletion events by time $T$ as $D(T) = \\int_{0}^{T} \\delta \\, S(\\tau) \\, d\\tau$, and the cumulative number of conversion events by time $T$ as $C(T) = \\int_{0}^{T} \\alpha \\, S(\\tau) \\, d\\tau$.\n\nYour task is to compute, for each parameter set, the quadruple $[S(T), R(T), D(T), C(T)]$. All reported quantities represent expected cell counts and must be interpreted in units of \"cells\". Time is measured in \"days\", and all rates are measured in $\\mathrm{day}^{-1}$. No angle units are involved. Express all results as real numbers.\n\nUse the following test suite (each tuple is $(S_0, R_0, \\delta, \\alpha, \\mu, T)$):\n- Case A (general non-degenerate): $(100000, 0, 0.2, 0.1, 0.05, 14)$,\n- Case B (no conversion): $(20000, 1000, 0.3, 0, 0.1, 10)$,\n- Case C (no deletion): $(50000, 0, 0, 0.2, 0.1, 7)$,\n- Case D (no Treg loss): $(1000, 0, 0.05, 0.15, 0, 30)$,\n- Case E (matched loss and total exit rates): $(10000, 100, 0.2, 0.3, 0.5, 5)$,\n- Case F (initial-time boundary): $(12345, 67, 0.1, 0.2, 0.3, 0)$.\n\nYour program should produce a single line of output containing the results aggregated for all cases, in order A through F, as a comma-separated list enclosed in square brackets, with no spaces, by concatenating the quadruples in case order. Thus the output format is $[S_A(T),R_A(T),D_A(T),C_A(T),S_B(T),R_B(T),D_B(T),C_B(T),\\dots,S_F(T),R_F(T),D_F(T),C_F(T)]$. All values are to be reported as real numbers representing counts of cells.", "solution": "The problem presented is a well-posed system of linear ordinary differential equations (ODEs) describing the population dynamics of T cells, a standard approach in mathematical immunology. The premises are scientifically sound within the context of a simplified model, and all parameters and initial conditions are provided. We can therefore proceed with deriving an analytical solution.\n\nThe system is defined by:\n$$ \\dfrac{dS}{dt} = -(\\delta + \\alpha) S(t) $$\n$$ \\dfrac{dR}{dt} = \\alpha S(t) - \\mu R(t) $$\nwith initial conditions $S(0) = S_0$ and $R(0) = R_0$.\n\nFirst, we solve for the population of self-reactive conventional T cells, $S(t)$. The equation for $S(t)$ is a first-order, linear, homogeneous ODE with constant coefficients.\nLet $\\lambda = \\delta + \\alpha$ be the total exit rate from the conventional T cell compartment. The equation becomes $\\dfrac{dS}{dt} = -\\lambda S(t)$.\nThis equation can be solved by separation of variables or by using the characteristic equation. The general solution is $S(t) = C e^{-\\lambda t}$ for some constant $C$.\nUsing the initial condition $S(0) = S_0$, we find $S_0 = C e^0 = C$.\nThus, the solution for $S(t)$ is:\n$$ S(t) = S_0 e^{-(\\delta + \\alpha)t} $$\n\nNext, we solve for the population of induced regulatory T cells, $R(t)$. We substitute the solution for $S(t)$ into the second ODE:\n$$ \\dfrac{dR}{dt} = \\alpha (S_0 e^{-(\\delta + \\alpha)t}) - \\mu R(t) $$\nRearranging this into the standard form for a first-order linear non-homogeneous ODE:\n$$ \\dfrac{dR}{dt} + \\mu R(t) = \\alpha S_0 e^{-(\\delta + \\alpha)t} $$\nWe solve this using the method of integrating factors. The integrating factor is $I(t) = e^{\\int \\mu dt} = e^{\\mu t}$. Multiplying the equation by $I(t)$ gives:\n$$ e^{\\mu t} \\dfrac{dR}{dt} + \\mu e^{\\mu t} R(t) = \\alpha S_0 e^{\\mu t} e^{-(\\delta + \\alpha)t} $$\nThe left side is the derivative of a product:\n$$ \\dfrac{d}{dt} \\left( R(t) e^{\\mu t} \\right) = \\alpha S_0 e^{(\\mu - \\delta - \\alpha)t} $$\nIntegrating both sides with respect to $t$:\n$$ R(t) e^{\\mu t} = \\int \\alpha S_0 e^{(\\mu - \\delta - \\alpha)t} dt $$\nThe solution depends on whether the exponent in the integrand is zero. Let $\\lambda = \\delta + \\alpha$.\n\nCase 1: $\\mu \\neq \\lambda$.\n$$ R(t) e^{\\mu t} = \\frac{\\alpha S_0}{\\mu - \\lambda} e^{(\\mu - \\lambda)t} + C' $$\nwhere $C'$ is the constant of integration. Solving for $R(t)$:\n$$ R(t) = \\frac{\\alpha S_0}{\\mu - \\lambda} e^{-\\lambda t} + C' e^{-\\mu t} $$\nUsing the initial condition $R(0) = R_0$:\n$$ R_0 = \\frac{\\alpha S_0}{\\mu - \\lambda} + C' \\implies C' = R_0 - \\frac{\\alpha S_0}{\\mu - \\lambda} $$\nSubstituting $C'$ back gives the solution for $R(t)$:\n$$ R(t) = R_0 e^{-\\mu t} + \\frac{\\alpha S_0}{\\mu - (\\delta + \\alpha)} \\left( e^{-(\\delta + \\alpha)t} - e^{-\\mu t} \\right) $$\n\nCase 2: $\\mu = \\lambda = \\delta + \\alpha$.\nIn this case, the exponent in the integral is zero, so $e^{(\\mu - \\lambda)t} = 1$. The integration becomes:\n$$ \\dfrac{d}{dt} \\left( R(t) e^{\\mu t} \\right) = \\alpha S_0 $$\n$$ R(t) e^{\\mu t} = \\alpha S_0 t + C'' $$\nSolving for $R(t)$:\n$$ R(t) = (\\alpha S_0 t + C'') e^{-\\mu t} $$\nUsing the initial condition $R(0) = R_0$:\n$$ R_0 = (\\alpha S_0 \\cdot 0 + C'') e^0 \\implies C'' = R_0 $$\nThe solution for $R(t)$ in this special case is:\n$$ R(t) = (R_0 + \\alpha S_0 t) e^{-\\mu t} $$\n\nFinally, we compute the cumulative numbers of deletion events, $D(T)$, and conversion events, $C(T)$. These are defined by integrals:\n$$ D(T) = \\int_{0}^{T} \\delta \\, S(\\tau) \\, d\\tau $$\n$$ C(T) = \\int_{0}^{T} \\alpha \\, S(\\tau) \\, d\\tau $$\nWe first evaluate the integral of $S(\\tau)$:\n$$ \\int_{0}^{T} S(\\tau) d\\tau = \\int_{0}^{T} S_0 e^{-(\\delta + \\alpha)\\tau} d\\tau $$\nLet $\\lambda = \\delta + \\alpha$. If $\\lambda \\neq 0$:\n$$ \\int_{0}^{T} S_0 e^{-\\lambda \\tau} d\\tau = S_0 \\left[ -\\frac{1}{\\lambda} e^{-\\lambda \\tau} \\right]_{0}^{T} = -\\frac{S_0}{\\lambda} (e^{-\\lambda T} - 1) = \\frac{S_0}{\\lambda} (1 - e^{-\\lambda T}) $$\nIf $\\lambda = 0$ (which implies $\\delta=0$ and $\\alpha=0$ as rates are non-negative), then $S(\\tau)=S_0$, and the integral is $S_0 T$.\n\nFor $\\lambda = \\delta + \\alpha \\neq 0$:\n$$ D(T) = \\delta \\left( \\frac{S_0}{\\delta + \\alpha} (1 - e^{-(\\delta + \\alpha)T}) \\right) = \\frac{\\delta S_0}{\\delta + \\alpha} (1 - e^{-(\\delta + \\alpha)T}) $$\n$$ C(T) = \\alpha \\left( \\frac{S_0}{\\delta + \\alpha} (1 - e^{-(\\delta + \\alpha)T}) \\right) = \\frac{\\alpha S_0}{\\delta + \\alpha} (1 - e^{-(\\delta + \\alpha)T}) $$\nIf $\\lambda = \\delta + \\alpha = 0$, then $\\delta=0$ and $\\alpha=0$, which implies $D(T)=0$ and $C(T)=0$. These results are consistent with the limit of the general expressions as $\\lambda \\to 0$.\nA useful consistency check is the conservation of cells originating from the $S$ compartment: the initial population $S_0$ must equal the sum of those remaining, $S(T)$, those deleted, $D(T)$, and those converted, $C(T)$.\n$$ S_0 = S(T) + D(T) + C(T) $$\n$$ S_0 = S_0 e^{-(\\delta+\\alpha)T} + \\frac{\\delta S_0}{\\delta + \\alpha} (1 - e^{-(\\delta + \\alpha)T}) + \\frac{\\alpha S_0}{\\delta + \\alpha} (1 - e^{-(\\delta + \\alpha)T}) $$\n$$ S_0 = S_0 e^{-(\\delta+\\alpha)T} + \\frac{(\\delta + \\alpha) S_0}{\\delta + \\alpha} (1 - e^{-(\\delta + \\alpha)T}) $$\n$$ S_0 = S_0 e^{-(\\delta+\\alpha)T} + S_0 (1 - e^{-(\\delta + \\alpha)T}) = S_0 $$\nThe identity holds.\n\nTo summarize, for a given set of parameters $(S_0, R_0, \\delta, \\alpha, \\mu, T)$, the quadruple $[S(T), R(T), D(T), C(T)]$ is calculated as follows:\nLet $\\lambda = \\delta + \\alpha$.\n1.  $S(T) = S_0 e^{-\\lambda T}$\n2.  If $|\\mu - \\lambda| < \\epsilon$ for a small tolerance $\\epsilon$ (e.g., $10^{-9}$), use the degenerate case formula for $R(T)$:\n    $R(T) = (R_0 + \\alpha S_0 T) e^{-\\mu T}$\n    Otherwise, use the general formula:\n    $R(T) = R_0 e^{-\\mu T} + \\frac{\\alpha S_0}{\\mu - \\lambda} (e^{-\\lambda T} - e^{-\\mu T})$\n3.  If $\\lambda < \\epsilon$, then $D(T) = 0$ and $C(T) = 0$.\n    Otherwise:\n    $D(T) = \\frac{\\delta S_0}{\\lambda} (1 - e^{-\\lambda T})$\n    $C(T) = \\frac{\\alpha S_0}{\\lambda} (1 - e^{-\\lambda T})$\n\nWe will now implement these formulas to solve for the provided test cases.", "answer": "[165.29888822158655,7581.411138810629,66556.46740785427,33278.233703927136,995.741368553213,367.87944117144233,19004.258631446788,0.0,12394.383333918037,36253.94825964955,0.0,37605.61666608196,0.01831563888873418,250.0,666.6544562407409,999.9816843611112,820.8499862389883,1239.4800361250325,3671.660005504405,5507.490008256607,12345.0,67.0,0.0,0.0]", "id": "5016553"}]}